Cck2r蛋白
WebJul 1, 2024 · targeted radiotherapy. Cholecystokinin-2 receptors (CCK2R) are expressed at high incidence in medullary thyroid carcinomas (MTC, > 90%), small cell lung cancers … WebJan 1, 2024 · 2. Development of Radiolabeled Peptide Analogs Targeting the CCK2R. For in vitro evaluations, exploring the binding affinity of a new radioligand to its biological target, as well as in vivo biodistribution studies, investigating the tumor uptake in animal xenograft models, a suitable cell model is substantial. This cell model should express the …
Cck2r蛋白
Did you know?
Web购买Abcam重组人CCK2-R蛋白(ab152260),经WB,ELISA,SDS-PAGE验证。 蛋白片段。 提供28,000多种信号蛋白、细胞因子、趋化因子、生长因子等产品。 Web一抗 Anti-Leptin Receptor antibody (ab104403) 蛋白 Recombinant Human Nicotinic Acetylcholine Receptor beta 2/CHRNB2 protein (ab152280) 一抗 Anti-CCK2-R antibody (ab77077) 查看更多相关产品.
http://xuebao.jnmc.edu.cn/ch/reader/create_pdf.aspx?file_no=20240412&year_id=2024&quarter_id=4&falg=1 http://www.fluoroprobe.com/archives/tag/%e5%8d%a1%e6%af%94
WebMar 21, 2024 · The new minigastrin analog DOTA-MGS8 targeting the cholecystokinin-2 receptor (CCK2R) used in this study displays the combination of two site-specific modifications within the C-terminal receptor binding sequence together with an additional N-terminal amino acid substitution preventing fast metabolic degradation. Within this study, … http://www.chinaqking.com/yc/2024/2025223.html
Web目的:研究胃泌素对胃癌细胞COX-2基因的调节以及对胃癌细胞增殖的影响,探讨相关信号转导通路与关键信号分子,进一步明确胃泌素调控COX-2表达的具体分子机制。. 方法: 1.研究对象:选取两株不同分化程度且CCK2R阳性的胃癌细胞SGC-7901与MKN-45作为研究对象 …
WebThe cholecystokinin 2 receptor (CCK2R/CCKBR) is expressed in gastrointestinal stromal tumours (GISTs). We sought to investigate the role of CCK2R in GIST pathogenesis. … nagin drama indian first episodeWebApr 1, 2024 · Specific targeting of MTC cells with radiolabeled minigastrin analogs has the potential to improve imaging and to allow peptide receptor radionuclide therapy, as … nagin disease in marathiWebThe clinical translation of CCK2R targeting has been prevented due to high kidney uptake or low metabolic stability of the different radiopeptides developed. Great efforts in radiopharmaceutical development have been undertaken to overcome these limitations. Various modifications in the linear peptide sequence of MG have been introduced mainly ... medigen biotechnology corp stockWebAug 26, 2024 · Debio 1124 is a new-generation peptide analogue of minigastrin, coupled to the isotope Lutetium 177 (177Lu) designed to selectively deliver molecular radiotherapy to tumor cells expressing the Cholecystokinin B Receptor (CCK2R). The compound can be used as both a diagnostic tool during initial imaging step and subsequently as an … medigest consultingWeb蛋白质与肽 按产品类型 蛋白质组学工具 激动剂、活化剂、拮抗剂与抑制剂 细胞株和裂解液 多重miRNA检测 多因子分析试剂盒 按研究领域 癌症 心血管 细胞生物学 表观遗传学 代谢 发育生物学 按研究领域 免疫学 微生物学 神经科学 信号转导 干细胞 medigenics consultingWebMar 18, 2015 · CCK2R in the brain is inaccessible to drugs that cannot pass the blood brain barrier, this restricted expression pattern renders CCK2R a possible candidate for ligand-targeted drug delivery. We report here the design, synthesis, and biological evaluation of two highly potent CCK2R-targeted chemo-therapeutic agents and demonstrate their efficacy … medigence network private limitedWeb蛋白; 基因与染色体 ... CI-988 (PD134308) is a potent, selective and orally activeCCK2R (cholecystokinin 2 receptor)antagonist with anIC 50 of 1.7 nM for mouse cortex CCK2. CI-988 shows >1600-fold selectivity for CCK2 over CCK1 receptor. CI-988 has anxiolytic and anti-tumor effects [1] [2] [3]. nagi neo the world ends with you